Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionAcima Private Wealth, Llc
Latest Disclosed Ownership1,806 shares
Latest Disclosed Value $ 806,451
Acima Private Wealth, Llc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 6, 2026 - Acima Private Wealth, Llc filed a 13F-HR form disclosing ownership of 1,806 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $806,451 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 1,806 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $773,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 0 0.00 806 -1.47 0.2531
2026-01-15 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 0 0.00 819 15.70 0.2541
2025-11-10 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 0 0.00 707 -12.06 0.2215
2025-07-24 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 0 0.00 804 -8.11 0.2740
2025-05-09 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 0 0.00 876 20.36 0.3142
2025-02-05 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,806 -1,275 -41.38 727 -49.23 0.2448
2024-11-12 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,081 0 0.00 1,433 -0.83 0.4803
2024-07-30 2024-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,081 0 0.00 1,444 12.20 0.5306
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,081 0 0.00 1,288 2.71 0.4748
2024-02-29 2023-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,081 0 0.00 1,254 16.99 0.4895
2024-02-29 2023-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,081 -299 -8.85 1,071 -9.92 0.4766
2024-02-29 2023-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,380 -58 -1.69 1,189 9.79 0.5693
2024-02-29 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,438 0 0.00 1,083 9.17 0.5319
2024-02-29 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,438 -401 -10.45 993 -10.71 0.5090
2024-02-29 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 1,112 2.78 0.5713
2024-02-29 2022-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 1,082 7.88 0.5399
2022-05-02 2022-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 1,002 18.86 0.4628
2022-03-10 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 843 21.12 0.3627
2021-11-09 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 696 -10.08 0.3199
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 774 -6.18 0.3553
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 825 -9.04 0.4054
2021-05-14 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 0 0.00 907 -13.21 0.4697
2021-05-14 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 -16 -0.42 1,045 -6.61 0.6302
2021-05-14 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 0 0.00 1,119 22.03 0.7228
2020-05-01 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 0 0.00 917 8.65 0.7062
2020-01-24 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 0 0.00 844 29.25 0.5831
2019-10-30 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 0 0.00 653 -7.64 0.4990
2019-07-23 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 0 0.00 707 -0.28 0.5576
2019-05-06 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,855 16 0.42 709 11.48 0.6066
2019-02-07 2018-12-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 3,839 3,839 636 0.6230
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.